Market Cap 6.40B
Revenue (ttm) 268.09M
Net Income (ttm) 124.45M
EPS (ttm) N/A
PE Ratio 42.34
Forward PE 73.41
Profit Margin 46.42%
Debt to Equity Ratio 0.00
Volume 368,100
Avg Vol 342,244
Day's Range N/A - N/A
Shares Out 20.04M
Stochastic %K 98%
Beta 1.10
Analysts Strong Sell
Price Target $271.00

Company Profile

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also pr...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 550 7500
Address:
555 Heritage Drive, Suite 200, Jupiter, United States
MikeyMcDermott
MikeyMcDermott Jul. 4 at 12:23 AM
Paul Hastings, eh? $SPRO $LGND ? $XOMA ? $KLRA $GSK ?
0 · Reply
JamesTaulman
JamesTaulman Jul. 3 at 2:24 AM
$LGND – THU: Some Consolidation Action Here Above $300 Would Be Ideal 8:30 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/thu-7-2-cinf-continues-to-get-extended-from-the-10-dma-at-180-74/
0 · Reply
JamesTaulman
JamesTaulman Jul. 2 at 3:25 AM
$LGND – WED: Finally Prints a Down Day – Volume Still Elevated 10:30 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/wed-7-1-lgnd-finally-prints-a-down-day-volume-still-elevated/
0 · Reply
BioRich
BioRich Jul. 1 at 4:46 PM
$TEM Stocktwits Q2 Quarterly Filing: @BioRich Top 50 portfolio positions: 1) GUTS 2) ABVX 3) IBRX 4) ALT 5) KYTX 6) DAVE 7) CADL 8) MIST 9) UEC 10) OTLK 11) CAPR 12) TGTX 13) SABS 14) NVAX 15) LEGN 16) VKTX 17) OCUL 18) SOFI 19) BBIO 20) SGP 21) VNDA 22) SHAZ 23) NRXP 24) GPCR 25) EWTX 26) TLSA 27) SKM 28) MLTX 29) SNDX 30) JMIA 31) NKTR 32) VVOS 33) RGNX 35) ARRNF 36) CRMD 37) WVE 38) NUVB 39) SMMT 40) ANNX 41) $CGON 42) TEM 43) $IVA 44) $PSN 45) $LGND 46) IMVT 47) MPLT 48)NNE 49) ARDX 50) COGT If I own it, I believe in it. What am I missing? Hold too much? Not enough? Look forward to your feedback! Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some (more) money. Cheers!
2 · Reply
tyogs
tyogs Jul. 1 at 4:08 AM
$LGND not the time to chase. Maybe a little room to run then pullback.
0 · Reply
JamesTaulman
JamesTaulman Jul. 1 at 3:29 AM
$LGND – MON: Continues Trading Higher on Above Average Volume 9:30 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/tue-6-30-lgnd-continues-trading-higher-on-above-average-volume/
0 · Reply
JamesTaulman
JamesTaulman Jun. 30 at 3:14 AM
$LGND – MON: Shows Continued Strong Bullish Action 8:30 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/mon-6-29-lgnd-shows-continued-strong-bullish-action/
0 · Reply
Doozio
Doozio Jun. 30 at 2:23 AM
$LGND ary ENTA 🐒🍌🧠⏰♾️
0 · Reply
JamesTaulman
JamesTaulman Jun. 27 at 2:21 AM
$LGND – FRI: Bullish Action Continues With a +2.6% Gains on a +263% Increase in Volume 9:00 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/fri-6-26-lgnd-bullish-action-continues-with-a-2-6-gains-on-a-263-increase-in-volume/
0 · Reply
JamesTaulman
JamesTaulman Jun. 26 at 2:11 AM
$LGND – THU: Bullish Action Continues With Sharp Gains on +152% Increase in Volume 8:00 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/thu-6-25-lgnd-bullish-action-continues-with-sharp-gains-on-152-increase-in-volume/
0 · Reply
Latest News on LGND
Ligand Announces Closing of Convertible Senior Notes Offering

Jun 25, 2026, 4:01 PM EDT - 9 days ago

Ligand Announces Closing of Convertible Senior Notes Offering


Ligand prices upsized $625M convertible senior note offering

2026-06-23T12:39:14.000Z - 11 days ago

Ligand prices upsized $625M convertible senior note offering


Ligand Announces 2026 Investor Day in New York City

Jun 10, 2026, 7:00 AM EDT - 24 days ago

Ligand Announces 2026 Investor Day in New York City


Ligand price target raised to $266 from $263 at BofA

2026-05-28T14:28:37.000Z - 5 weeks ago

Ligand price target raised to $266 from $263 at BofA

TVTX


Ligand to Participate in June Investor Conferences

May 27, 2026, 4:01 PM EDT - 5 weeks ago

Ligand to Participate in June Investor Conferences


Ligand Pharmaceuticals Proxy statement: Proxy filing

May 18, 2026, 8:00 AM EDT - 6 weeks ago

Ligand Pharmaceuticals Proxy statement: Proxy filing


Ligand reports Q1 adjusted EPS $1.63, consensus $1.80

2026-05-07T15:17:53.000Z - 2 months ago

Ligand reports Q1 adjusted EPS $1.63, consensus $1.80


Ligand Pharmaceuticals Earnings Call Transcript: Q1 2026

May 7, 2026, 8:30 AM EDT - 2 months ago

Ligand Pharmaceuticals Earnings Call Transcript: Q1 2026


Ligand Pharmaceuticals Earnings release: Q1 2026

May 7, 2026, 8:30 AM EDT - 2 months ago

Ligand Pharmaceuticals Earnings release: Q1 2026


Ligand Pharmaceuticals Slides: Q1 2026

May 7, 2026, 8:30 AM EDT - 2 months ago

Ligand Pharmaceuticals Slides: Q1 2026


Ligand Pharmaceuticals Quarterly report: Q1 2026

May 7, 2026, 8:30 AM EDT - 2 months ago

Ligand Pharmaceuticals Quarterly report: Q1 2026


Ligand Reports First Quarter 2026 Financial Results

May 7, 2026, 7:00 AM EDT - 2 months ago

Ligand Reports First Quarter 2026 Financial Results


Orchestra BioMed receives $15M payment from Ligand

2026-05-07T05:00:15.000Z - 2 months ago

Orchestra BioMed receives $15M payment from Ligand

OBIO


Ligand to Participate in May Investor Conferences

May 5, 2026, 4:01 PM EDT - 2 months ago

Ligand to Participate in May Investor Conferences


Ligand price target raised to $289 from $243 at H.C. Wainwright

2026-04-30T10:10:18.000Z - 2 months ago

Ligand price target raised to $289 from $243 at H.C. Wainwright


Ligand price target raised to $252 from $235 at RBC Capital

2026-04-28T12:05:59.000Z - 2 months ago

Ligand price target raised to $252 from $235 at RBC Capital


Ligand Pharmaceuticals Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Ligand Pharmaceuticals Proxy statement: Proxy filing


Ligand price target raised to $255 from $230 at Stifel

2026-04-27T18:10:15.000Z - 2 months ago

Ligand price target raised to $255 from $230 at Stifel

XOMA


Ligand price target raised to $260 from $250 at BofA

2026-04-27T18:00:17.000Z - 2 months ago

Ligand price target raised to $260 from $250 at BofA

XOMA


Ligand Pharmaceuticals Transcript: M&A announcement

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Ligand Pharmaceuticals Transcript: M&A announcement


Ligand Pharmaceuticals Press release: M&A announcement

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Ligand Pharmaceuticals Press release: M&A announcement


Ligand Pharmaceuticals Slides: M&A announcement

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Ligand Pharmaceuticals Slides: M&A announcement


Ligand Pharmaceuticals Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Ligand Pharmaceuticals Proxy statement: Proxy filing


Ligand to acquire Xoma for $39.00 per share in cash

2026-04-27T11:26:31.000Z - 2 months ago

Ligand to acquire Xoma for $39.00 per share in cash

XOMA


Ligand to buy Xoma for $39 per share, WSJ reports

2026-04-27T10:38:33.000Z - 2 months ago

Ligand to buy Xoma for $39 per share, WSJ reports

XOMA


Ligand Pharmaceuticals Is Buying Xoma for Nearly $740 Million

Apr 27, 2026, 6:00 AM EDT - 2 months ago

Ligand Pharmaceuticals Is Buying Xoma for Nearly $740 Million


Ligand Pharmaceuticals Proxy statement: Proxy filing

Apr 21, 2026, 8:00 AM EDT - 2 months ago

Ligand Pharmaceuticals Proxy statement: Proxy filing


Ligand Pharmaceuticals Proxy statement: Proxy filing

Apr 21, 2026, 8:00 AM EDT - 2 months ago

Ligand Pharmaceuticals Proxy statement: Proxy filing


Ligand price target raised to $282 from $276 at Citi

2026-04-15T10:46:47.000Z - 2 months ago

Ligand price target raised to $282 from $276 at Citi


Ligand price target raised to $250 from $244 at BofA

2026-04-14T11:19:24.000Z - 2 months ago

Ligand price target raised to $250 from $244 at BofA

TVTX


Ligand to Participate in March Investor Conferences

Mar 4, 2026, 7:00 AM EST - 4 months ago

Ligand to Participate in March Investor Conferences


Ligand Pharmaceuticals Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

Ligand Pharmaceuticals Earnings Call Transcript: Q4 2025


Ligand Pharmaceuticals Annual report: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

Ligand Pharmaceuticals Annual report: Q4 2025


Ligand Pharmaceuticals Earnings release: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

Ligand Pharmaceuticals Earnings release: Q4 2025


Ligand Pharmaceuticals Slides: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

Ligand Pharmaceuticals Slides: Q4 2025


Ligand Pharmaceuticals Transcript: Investor Day 2025

Dec 9, 2025, 10:30 AM EST - 7 months ago

Ligand Pharmaceuticals Transcript: Investor Day 2025


Ligand Pharmaceuticals Press release: FY 2025

Dec 9, 2025, 10:30 AM EST - 7 months ago

Ligand Pharmaceuticals Press release: FY 2025


Ligand Pharmaceuticals Slides: FY 2025

Dec 9, 2025, 10:30 AM EST - 7 months ago

Ligand Pharmaceuticals Slides: FY 2025


Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance

Dec 9, 2025, 7:00 AM EST - 7 months ago

Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance


Ligand Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

Ligand Pharmaceuticals Earnings Call Transcript: Q3 2025


Ligand Pharmaceuticals Quarterly report: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

Ligand Pharmaceuticals Quarterly report: Q3 2025


Ligand Pharmaceuticals Earnings release: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

Ligand Pharmaceuticals Earnings release: Q3 2025


Ligand Pharmaceuticals Slides: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

Ligand Pharmaceuticals Slides: Q3 2025


Ligand to Participate in November Investor Conferences

Oct 30, 2025, 4:01 PM EDT - 8 months ago

Ligand to Participate in November Investor Conferences


Ligand to Host Investor Day on December 9, 2025

Oct 16, 2025, 7:00 AM EDT - 9 months ago

Ligand to Host Investor Day on December 9, 2025


Ligand to Participate in September Investor Conferences

Aug 19, 2025, 4:00 PM EDT - 11 months ago

Ligand to Participate in September Investor Conferences


Ligand Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 11 months ago

Ligand Pharmaceuticals Earnings Call Transcript: Q2 2025


Ligand Pharmaceuticals Quarterly report: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 11 months ago

Ligand Pharmaceuticals Quarterly report: Q2 2025


Ligand Pharmaceuticals Earnings release: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 11 months ago

Ligand Pharmaceuticals Earnings release: Q2 2025


Ligand Pharmaceuticals Slides: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 11 months ago

Ligand Pharmaceuticals Slides: Q2 2025


Ligand Partner Pelthos Therapeutics Launches ZELSUVMI™

Jul 10, 2025, 8:00 AM EDT - 1 year ago

Ligand Partner Pelthos Therapeutics Launches ZELSUVMI™


Ligand Announces 2025 Investor Day in New York City

Jun 11, 2025, 7:00 AM EDT - 1 year ago

Ligand Announces 2025 Investor Day in New York City


Ligand to Ring the Nasdaq Opening Bell on May 19, 2025

May 14, 2025, 7:00 AM EDT - 1 year ago

Ligand to Ring the Nasdaq Opening Bell on May 19, 2025


Ligand Pharmaceuticals Earnings Call Transcript: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Ligand Pharmaceuticals Earnings Call Transcript: Q1 2025


Ligand Pharmaceuticals Quarterly report: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Ligand Pharmaceuticals Quarterly report: Q1 2025


Ligand Pharmaceuticals Earnings release: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Ligand Pharmaceuticals Earnings release: Q1 2025


Ligand Pharmaceuticals Slides: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Ligand Pharmaceuticals Slides: Q1 2025


Ligand Reports First Quarter 2025 Financial Results

May 8, 2025, 7:00 AM EDT - 1 year ago

Ligand Reports First Quarter 2025 Financial Results


Ligand Pharmaceuticals Proxy statement: Proxy Filing

Apr 22, 2025, 8:00 AM EDT - 1 year ago

Ligand Pharmaceuticals Proxy statement: Proxy Filing


Ligand Pharmaceuticals Proxy statement: Proxy Filing

Apr 22, 2025, 8:00 AM EDT - 1 year ago

Ligand Pharmaceuticals Proxy statement: Proxy Filing


Ligand Pharmaceuticals Earnings Call Transcript: Q4 2024

Feb 27, 2025, 8:30 AM EST - 1 year ago

Ligand Pharmaceuticals Earnings Call Transcript: Q4 2024


Ligand Pharmaceuticals Annual report: Q4 2024

Feb 27, 2025, 8:30 AM EST - 1 year ago

Ligand Pharmaceuticals Annual report: Q4 2024


Ligand Pharmaceuticals Earnings release: Q4 2024

Feb 27, 2025, 8:30 AM EST - 1 year ago

Ligand Pharmaceuticals Earnings release: Q4 2024


Ligand Pharmaceuticals Slides: Q4 2024

Feb 27, 2025, 8:30 AM EST - 1 year ago

Ligand Pharmaceuticals Slides: Q4 2024


Ligand Pharmaceuticals Transcript: Investor Day 2024

Dec 10, 2024, 10:30 AM EST - 1 year ago

Ligand Pharmaceuticals Transcript: Investor Day 2024


Ligand Pharmaceuticals Slides: FY 2024

Dec 10, 2024, 10:30 AM EST - 1 year ago

Ligand Pharmaceuticals Slides: FY 2024


Ligand to Present at Stifel 2024 Healthcare Conference

Nov 14, 2024, 8:00 AM EST - 1 year ago

Ligand to Present at Stifel 2024 Healthcare Conference


Ligand Pharmaceuticals Earnings Call Transcript: Q3 2024

Nov 7, 2024, 8:30 AM EST - 1 year ago

Ligand Pharmaceuticals Earnings Call Transcript: Q3 2024


Ligand Pharmaceuticals Quarterly report: Q3 2024

Nov 7, 2024, 8:30 AM EST - 1 year ago

Ligand Pharmaceuticals Quarterly report: Q3 2024


Ligand Pharmaceuticals Earnings release: Q3 2024

Nov 7, 2024, 8:30 AM EST - 1 year ago

Ligand Pharmaceuticals Earnings release: Q3 2024


Ligand Pharmaceuticals Slides: Q3 2024

Nov 7, 2024, 8:30 AM EST - 1 year ago

Ligand Pharmaceuticals Slides: Q3 2024


MikeyMcDermott
MikeyMcDermott Jul. 4 at 12:23 AM
Paul Hastings, eh? $SPRO $LGND ? $XOMA ? $KLRA $GSK ?
0 · Reply
JamesTaulman
JamesTaulman Jul. 3 at 2:24 AM
$LGND – THU: Some Consolidation Action Here Above $300 Would Be Ideal 8:30 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/thu-7-2-cinf-continues-to-get-extended-from-the-10-dma-at-180-74/
0 · Reply
JamesTaulman
JamesTaulman Jul. 2 at 3:25 AM
$LGND – WED: Finally Prints a Down Day – Volume Still Elevated 10:30 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/wed-7-1-lgnd-finally-prints-a-down-day-volume-still-elevated/
0 · Reply
BioRich
BioRich Jul. 1 at 4:46 PM
$TEM Stocktwits Q2 Quarterly Filing: @BioRich Top 50 portfolio positions: 1) GUTS 2) ABVX 3) IBRX 4) ALT 5) KYTX 6) DAVE 7) CADL 8) MIST 9) UEC 10) OTLK 11) CAPR 12) TGTX 13) SABS 14) NVAX 15) LEGN 16) VKTX 17) OCUL 18) SOFI 19) BBIO 20) SGP 21) VNDA 22) SHAZ 23) NRXP 24) GPCR 25) EWTX 26) TLSA 27) SKM 28) MLTX 29) SNDX 30) JMIA 31) NKTR 32) VVOS 33) RGNX 35) ARRNF 36) CRMD 37) WVE 38) NUVB 39) SMMT 40) ANNX 41) $CGON 42) TEM 43) $IVA 44) $PSN 45) $LGND 46) IMVT 47) MPLT 48)NNE 49) ARDX 50) COGT If I own it, I believe in it. What am I missing? Hold too much? Not enough? Look forward to your feedback! Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some (more) money. Cheers!
2 · Reply
tyogs
tyogs Jul. 1 at 4:08 AM
$LGND not the time to chase. Maybe a little room to run then pullback.
0 · Reply
JamesTaulman
JamesTaulman Jul. 1 at 3:29 AM
$LGND – MON: Continues Trading Higher on Above Average Volume 9:30 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/tue-6-30-lgnd-continues-trading-higher-on-above-average-volume/
0 · Reply
JamesTaulman
JamesTaulman Jun. 30 at 3:14 AM
$LGND – MON: Shows Continued Strong Bullish Action 8:30 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/mon-6-29-lgnd-shows-continued-strong-bullish-action/
0 · Reply
Doozio
Doozio Jun. 30 at 2:23 AM
$LGND ary ENTA 🐒🍌🧠⏰♾️
0 · Reply
JamesTaulman
JamesTaulman Jun. 27 at 2:21 AM
$LGND – FRI: Bullish Action Continues With a +2.6% Gains on a +263% Increase in Volume 9:00 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/fri-6-26-lgnd-bullish-action-continues-with-a-2-6-gains-on-a-263-increase-in-volume/
0 · Reply
JamesTaulman
JamesTaulman Jun. 26 at 2:11 AM
$LGND – THU: Bullish Action Continues With Sharp Gains on +152% Increase in Volume 8:00 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/thu-6-25-lgnd-bullish-action-continues-with-sharp-gains-on-152-increase-in-volume/
0 · Reply
JamesTaulman
JamesTaulman Jun. 25 at 2:04 AM
$LGND – WED: Volume-Backed Gains to Another New All-Time High Close 9:00 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/wed-6-24-lgnd-volume-backed-gains-to-another-new-all-time-high-close/
0 · Reply
Spicy_Trade
Spicy_Trade Jun. 24 at 12:43 AM
Ligand Pharmaceuticals Incorpor ( $LGND ) SpicyTrade - Daily Stock Analysis https://youtu.be/gLDsDqgBFUg?si=xg5zoLNlEd7nUerO
0 · Reply
Doozio
Doozio Jun. 23 at 4:26 PM
MNDY 🐑 are $LGND ary 🎁s ONTO 🐒🍌🧠⏰♾️
0 · Reply
JamesTaulman
JamesTaulman Jun. 23 at 2:15 AM
$LGND – MON: Dropped Below the 10 DMA Then Rallied to Close Well Above 8:00 PM – Starting a position here in LQDA as the stock trades higher from its 10 DMA on above-average volume and begins to break above ROUND-$70. That combination of price strength and volume support is a technical BUY SIGNAL. James’ Trader’s Tip: Round Numbers Often Matter • Round-number levels frequently act as support or resistance because traders watch them closely. • Stocks breaking above these levels on strong volume often attract additional buying interest. • When price, volume, and trend align, the odds of a successful breakout generally improve. https://buyingbreakouts.com/mon-6-22-lgnd-dropped-below-the-10-dma-then-rallied-to-close-well-above-2/
0 · Reply
OpenOutcrier
OpenOutcrier Jun. 22 at 1:07 PM
$LGND (-3.1% pre) Ligand plans $550M convertible notes offering due 2031 https://ooc.bz/l/105726
0 · Reply
JamesTaulman
JamesTaulman Jun. 19 at 2:47 AM
$LGND – THU: Continued Bullish Action With Volume-Backed Gains to New Highs 8:30 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/thu-6-18-lgnd-continued-bullish-action-with-volume-backed-gains-to-new-highs/
0 · Reply
Jwa68
Jwa68 Jun. 18 at 12:42 PM
$PTHS A $1M insider purchase from the CEO of $LGND.. let that sit in...
0 · Reply
Doozio
Doozio Jun. 17 at 9:24 PM
$XBI has been up 12 of the last 13 months and 13 of the last 15 since 🐒🍌🧠⏰♾️ began. They did say it wud get $LGND ary with a $LEGN of huckleberries.
1 · Reply
Jwa68
Jwa68 Jun. 16 at 12:41 PM
$PTHS Not just anyone buying $1M worth, but the CEO of $LGND ....pretty telling.
0 · Reply
JamesTaulman
JamesTaulman Jun. 16 at 2:18 AM
$LGND – MON: Welcomed Quieter Trading After Several Sessions With Above Average Volume Gains 7:45 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/mon-6-15-lgnd-welcomed-quieter-trading-after-several-sessions-with-above-average-volume-gains/
0 · Reply
JamesTaulman
JamesTaulman Jun. 12 at 3:46 AM
$LGND – THU: Solid Gains With a +22% Increase in Volume – New High Close 11:00 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/thu-6-11-lgnd-solid-gains-with-a-22-increase-in-volume-new-high-close/
0 · Reply
JamesTaulman
JamesTaulman Jun. 11 at 2:45 AM
$LGND – WED: Jumped Higher Then Pulled Back – Next Support Is at the Round-$240 8:00 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/wed-6-10-lgnd-jumped-higher-then-pulled-back-next-support-is-at-the-round-240/
0 · Reply